ANGIOPLASTY CATHETERS - GLOBAL MARKETS

138 Pages | 70 Exhibits | 2017 Analysis | Forecasts Through 2021

OVERVIEW:
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for angioplasty catheters.

ANGIOPLASTY CATHETERS MARKET HIGHLIGHTS

  • The global market for angioplasty catheters is seeing low growth due to a number of factors, including: declining average sale price(s) of balloon catheters, earlier identification and treatment of cardiovascular disease, and high costs associated with performing minimally invasive cardiovascular procedures.
  • In 2016, the majority of total angioplasty catheter sales were attributable to sales of POBA catheters, which made up approximately 60% of total sales. DCB catheters are forecast to experience the strongest growth in terms of total unit sales.
  • The market for angioplasty catheters is anticipated to experience a low CAGR of 3.6% during the forecast period (2016-21), reaching approximately $2.3bn in total product sales by 2021.
  • The increasing burden of cardiovascular diseases (CVDs) and the growing elderly demographic, a high risk demographic for the development of CVDs, are the main factors driving growth in product sales. In addition, positive clinical data supporting the usage of DCB catheters is supporting market growth.
  • The US market for angioplasty catheters accounted for approximately 36.4% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK) healthcare services in emerging markets.
Topics Covered Include:
  • An overview of angioplasty products, including plain old balloon angioplasty (POBA), drug coated balloon (DCB), cutting balloon, and scoring balloon catheters.
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segment.
  • Discussion of key drivers and limiters impacting the major product segments.
  • Country and region-specific insights that are influencing the utilization of angioplasty catheters and the performance of percutaneous transluminal angioplasty and percutaneous transluminal coronary angioplasty.
  • Physician device preferences and utilization rates.
  • A review of emerging technologies which could impact sales of existing devices.


TABLE OF CONTENTS:
EXECUTIVE SUMMARY
 
i. Cardiovascular diseases overview 
ii. Global angioplasty catheters market 
	a. Market drivers and limiters 
	b. Device segment insights
	c. Technology trends 
	d. Market leaders 
	e. Competitive strategies 
	f. Emerging competition 
iii. Methodology 

Exhibit ES-1: Angioplasty catheters global market forecast, 2016-21 
Exhibit ES-2: Global angioplasty catheters market, share by country/region, 2016 
Exhibit ES-3: Drivers and limiters of growth on the angioplasty catheters market 

1. CARDIOVASCULAR DISEASES OVERVIEW
 
1.1 Acute coronary syndrome 
	1.1.1 Atherosclerosis 
	1.1.2 Angina pectoris 
	1.1.3 Myocardial infarction 
	1.1.4 Diagnosis and treatment
1.2 Hypertension 
1.3 Peripheral vascular disease 
	1.3.1 Critical limb ischemia 
	1.3.2 Aneurysm 
	1.3.3 Deep vein thrombosis/pulmonary embolism 
	1.3.4 Diagnosis and treatment
1.4 Cerebrovascular disease 
	1.4.1 Diagnosis and treatment
1.5 Bibliography 

Exhibit 1-1: Estimated mortality due to ischemic heart disease and cerebrovascular disease, select countries 
Exhibit 1-2: Top 10 countries with the highest CVD death rates
Exhibit 1-3: Estimated incident cases for acute coronary syndrome, select countries 
Exhibit 1-4: Age-standardized incidence (000s) of angina pectoris, select regions
Exhibit 1-5: Clinical classification of acute myocardial infarction 
Exhibit 1-6: Age-standardized incidence (000s) of acute myocardial infarction, select regions 
Exhibit 1-7: Estimated incident cases of myocardial infarction, select countries 
Exhibit 1-8: Estimated prevalent cases of hypertension, select countries 
Exhibit 1-9: Mortality attributable to hypertensive diseases, select countries 
Exhibit 1-10: Estimated incident cases of DVT, select countries 
Exhibit 1-11: Estimated incident cases of PE, select countries 
Exhibit 1-12: Estimated incident cases of stroke, select countries 
Exhibit 1-13: Estimated prevalent cases of stroke, select countries
 
2. ANGIOPLASTY CATHETER PRODUCTS
 
2.1 Balloon angioplasty 
	2.1.1 Conventional balloon catheter products 
	2.1.2 Drug-coated balloon catheter products 
	2.1.3 Drug-coated balloon catheters in development 
	2.1.4 Cutting balloon catheter products 
	2.1.5 Scoring balloon catheter products 
2.2 Emerging technology 
2.3 Bibliography 

Exhibit 2-1: Advantages and disadvantages of balloon angioplasty
Exhibit 2-2: Clinical requirements of balloon catheters 
Exhibit 2-3: Advantages and disadvantages of OTW and RX balloon catheters 
Exhibit 2-4: Select images of balloon angioplasty catheters 
Exhibit 2-5: Select balloon catheters and manufacturers 
Exhibit 2-6: Select images of DCB catheters 
Exhibit 2-7: Select drug-coated balloon catheters and manufacturers 
Exhibit 2-8: Current clinical trials investigating drug-coated balloon catheters 
Exhibit 2-9: Select images of cutting balloon catheters 
Exhibit 2-10: Select images of scoring balloon catheters 

3. ANGIOPLASTY CATHETER PRODUCTS MARKET
 
3.1 Global market insights 
	3.1.1 Market value 
	3.1.2 Technology trends 
	3.1.3 Market drivers and limiters 
	3.1.4 Angioplasty catheters overview 
	3.1.5 Market leaders 
	3.1.6 Competitive strategies 
	3.1.7 Emerging competition 
3.2 Global competitors 
	3.2.1 Balloon angioplasty catheters 
	3.2.2 Drug-coated balloon angioplasty catheters 
	3.2.3 Cutting balloon angioplasty catheters 
	3.2.4 Scoring balloon angioplasty catheters 
3.3 Market forecast 
	3.3.1 Market forecast: US 
	3.3.2 Market forecast: five major EU markets 
	3.3.3 Market forecast: Japan 
	3.3.4 Market forecast: RoW 
3.4 Bibliography

Exhibit 3-1: Angioplasty catheters, global market forecast, 2016-21 
Exhibit 3-2: Angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21 
Exhibit 3-3: Global angioplasty catheters market, share by country/region, 2016 
Exhibit 3-4: Global angioplasty catheter sales combined market forecast ($m), by country/region, 2016-21 
Exhibit 3-5: Drivers and limiters of growth on the angioplasty catheters market 
Exhibit 3-6: Average sale price of selected angioplasty catheters in 2017 
Exhibit 3-7: Global POBA catheters market, share by supplier, 2016 
Exhibit 3-8: Global DCB catheters market, share by supplier, 2016 
Exhibit 3-9: Global scoring balloon catheters market, share by supplier, 2016 
Exhibit 3-10: US angioplasty procedure volumes forecast (000s), 2016-21 
Exhibit 3-11: US angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21
Exhibit 3-12: US POBA catheters market forecast, 2016-21 
Exhibit 3-13: US POBA catheters market, share by supplier, 2016 
Exhibit 3-14: US DCB catheters market forecast, 2016-21 
Exhibit 3-15: US DCB catheters market, share by supplier, 2016 
Exhibit 3-16: US cutting balloon catheters market forecast, 2016-21 
Exhibit 3-17: US scoring balloon catheters market forecast, 2016-21 
Exhibit 3-18: US scoring balloon catheters market, share by supplier, 2016 
Exhibit 3-19: Five major EU markets PTCA procedure volumes forecast (000s), 2016-21 
Exhibit 3-20: Five major EU markets PTA procedure volumes forecast (000s), 2016-21 
Exhibit 3-21: Five major EU markets angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21 
Exhibit 3-22: Five major EU markets POBA catheters market forecast, 2016-21 
Exhibit 3-23: Five major EU markets POBA catheters market, share by supplier, 2016 
Exhibit 3-24: Five major EU markets DCB catheters market forecast, 2016-21 
Exhibit 3-25: Five major EU markets DCB catheters market, share by supplier, 2016 
Exhibit 3-26: Five major EU markets cutting balloon catheters market forecast, 2016-21 
Exhibit 3-27: Five major EU markets scoring balloon catheters market forecast, 2016-21 
Exhibit 3-28: Five major EU markets scoring balloon catheters market, share by supplier, 2016 
Exhibit 3-29: Japan angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21
Exhibit 3-30: Japanese PCI procedure volumes forecast, 2016-21 
Exhibit 3-31: Japan POBA catheters market forecast, 2016-21 
Exhibit 3-32: Japan POBA catheters market, share by supplier, 2016 
Exhibit 3-33: Japan DCB catheters market forecast, 2016-21 
Exhibit 3-34: Japan cutting balloon catheters market forecast, 2016-21 
Exhibit 3-35: Japan scoring balloon catheters market forecast, 2016-21 
Exhibit 3-36: Japan scoring balloon catheters market, share by supplier, 2016  
Exhibit 3-37: RoW angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21 
Exhibit 3-38: RoW POBA catheters market forecast, 2016-21 
Exhibit 3-39: RoW POBA catheters market, share by supplier, 2016 
Exhibit 3-40: RoW DCB catheters market forecast, 2016-21 
Exhibit 3-41: RoW DCB catheters market, share by supplier, 2016 
Exhibit 3-42: RoW cutting balloon catheters market forecast, 2016-21 
Exhibit 3-43: RoW scoring balloon catheters market forecast, 2016-21 
Exhibit 3-44: RoW scoring balloon catheters market, share by supplier, 2016 

APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. Aachen Resonance
  2. Abbott
  3. Acandis
  4. Acotec Scientific
  5. Acrostak
  6. Alvimedica
  7. AMG International
  8. AngioDynamics
  9. ARTHESYS
  10. B. Braun Medical/B. Braun Melsungen
  11. Balton
  12. Bayer
  13. BD
  14. Biosensors International
  15. BIOTRONIK
  16. Boston Scientific
  17. C.R. Bard
  18. Cagent Vascular
  19. Cardinal Health
  20. Cardionovum
  21. Concept Medical
  22. Cook Medical/Cook Group
  23. Cordis/Cardinal Health
  24. ENDOCOR
  25. eucatech
  26. Eurocor
  27. Goodman/Nipro Corporation
  28. Hexacath
  29. IMeSI Italia
  30. InSitu Technologies
  31. iVascular
  32. Lepu Medical
  33. M.A. Med Alliance
  34. Medinol
  35. Medtronic
  36. Meril Life Sciences
  37. MicroPort Scientific
  38. Minvasys
  39. NATEC Medical
  40. Nipro
  41. OrbusNeich
  42. Philips/Royal Philips
  43. QT Vascular
  44. Rontis
  45. Scitech
  46. Shockwave Medical
  47. SIS Medical
  48. Spectranetics
  49. SurModics
  50. Terumo Interventional Systems
  51. Tokai Medical Products
  52. TriReme Medical
  53. VentureMed Group
Contact Us

Need help finding medtech research? Let us help you!